Disclosures for "Real-world Outcomes of Nusinersen or Onasemnogene Abeparvovec (OA) Monotherapy, or Switching to OA from Nusinersen in SMA Patients Aged ≥6 Months")
-
Dr. Dabbous has received personal compensation for serving as an employee of NOVARTIS GENE THERAPIES, INC.. Dr. Dabbous has stock in NOVARTIS GENE THERAPIES, INC.
-
Min Yang has nothing to disclose.
-
Mihaela Georgieva has nothing to disclose.
-
Walter Toro has received personal compensation for serving as an employee of Astellas. Walter Toro has received personal compensation for serving as an employee of Avexis. Walter Toro has received personal compensation for serving as an employee of Novartis Gene Therapies.
-
Ms. LaMarca has received personal compensation for serving as an employee of Novartis Gene Therapies.
-
Anish Patel has nothing to disclose.
-
Miss Anderson has nothing to disclose.
-
Ms. Akbarnejad has nothing to disclose.
-
Dr. Reyna has received personal compensation for serving as an employee of Novartis Gene Therapies.